Several studies have theorised the use of AQP4 therapies in several conditions, such as stroke and AD; but no specific human trials utilising AQP4 treatments for these have yet to be conducted from the date of this review and the exact mechanism of this remain complex and not fully comprehended [20,133,134]. Here, AQP4 is linked to Alzheimer disease.